Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Briemar Nominees is a trusted Australian pharmaceutical, medical device, and contract sachet manufacturer serving the healthcare and cosmetic industries. Founded in 1975 and operating from a specialized facility in Koo Wee Rup, Victoria, the company is licensed by the Therapeutic Goods Administration (TGA) to produce sterile and non-sterile therapeutic goods, complementary and OTC medicines, and Class I/IIa medical devices. Briemar specializes in high-precision sachet manufacturing and packaging, offering a diverse range of products including pre-injection alcohol swabs, sterile solution sachets, and various wet wipes. The company operates under strict adherence to the Code of Good Manufacturing Practice (GMP) and holds ISO 13485 and ISO 22716 accreditations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Briemar Nominees.